WDR5 and urinary bladder cancer: The association of WDR5 with BLACAT2 promotes H3K4 methylation and the upregulation of VEGF-C, a lymphangiogenic growth factor, thereby leading to bladder cancer-associated lymphangiogenesis and lymphatic metastasis [222].